WEEDRoundhill Cannabis ETF
Seeks capital growth.
By Roundhill Investments · Launched 2022
Annual Cost
0.41%
#2,144 of 6,040 · average
Fund Size
$9M
#5,017 of 6,040 · small
Return (1Y)
+21.8%
Track Record
4 years
#2,618 of 6,040 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$11,658+16.6%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Multi cap
Strategy
Active selection
Sector
Health careFocus
Biotech & Genomics
Holdings
By weightConcentration
Top 8 holdings = 99.9% of fundconcentrated
TREASURY BILL
68.8%
Curaleaf Holdings Inc
24.1%
First American Government Obli
13.4%
N/A
0.0%
N/A
-0.4%
N/A
-1.1%
N/A
-1.3%
N/A
-3.5%
Asset allocation
Stocks
90.3%
Other
9.6%
Cash
0.1%
By sector
Healthcare
60.0%
Consumer Defensive
17.3%
Real Estate
16.3%
Technology
6.3%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
102.4%High
Year-on-year price swings
Max drawdown
-88.1%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.19Below average
Sortino (3Y)
0.31Moderate downside risk
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks capital growth.
- Strategy
- Actively manages an ETF investing primarily in equity securities and total return swaps to provide exposure to the cannabis and hemp ecosystem. Focuses on small, medium, and large capitalization companies across emerging and developed markets, with at least 25% in the Pharmaceuticals, Biotechnology & Life Sciences sector.
- Inception date
- April 19, 2022
- Fund family
- Roundhill Investments
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save WEED to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18